{"count": 82, "results": [{"_id": "35909294", "pmid": 35909294, "pmcid": "PMC10286558", "title": "Repurposing Metformin for Vascular Disease", "journal": "Curr Med Chem", "authors": ["Triggle CR", "Marei I", "Ye K", "Ding H", "Anderson TJ", "Hollenberg MD", "Hill MA"], "date": "2022-07-29T00:00:00Z", "doi": "10.2174/0929867329666220729154615", "meta_date_publication": "2022 Jul 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50285.914, "text_hl": "Repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@Vascular Disease@@@", "citations": {"NLM": "Triggle CR, Marei I, Ye K, Ding H, Anderson TJ, Hollenberg MD, Hill MA. Repurposing Metformin for Vascular Disease Curr Med Chem. 2022 Jul 29;():. PMID: 35909294", "BibTeX": "@article{35909294, title={Repurposing Metformin for Vascular Disease}, author={Triggle CR and Marei I and Ye K and Ding H and Anderson TJ and Hollenberg MD and Hill MA}, journal={Curr Med Chem}}"}}, {"_id": "36359302", "pmid": 36359302, "pmcid": "PMC9687337", "title": "Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS", "journal": "Biomedicines", "authors": ["Martins AF", "Neto AC", "Rodrigues AR", "Oliveira SM", "Sousa-Mendes C", "Leite-Moreira A", "Gouveia AM", "Almeida H", "Neves D"], "date": "2022-11-01T00:00:00Z", "doi": "10.3390/biomedicines10112782", "meta_date_publication": "2022 Nov 1", "meta_volume": "10", "meta_issue": "11", "meta_pages": "", "score": 50273.34, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Prevents @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@Endothelial Dysfunction@@@ in @DISEASE_Endometriosis @DISEASE_MESH:D004715 @@@Endometriosis@@@ through Downregulation of @GENE_EDN1 @GENE_13614 @@@ET-1@@@ and Upregulation of eNOS", "citations": {"NLM": "Martins AF, Neto AC, Rodrigues AR, Oliveira SM, Sousa-Mendes C, Leite-Moreira A, Gouveia AM, Almeida H, Neves D. Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS Biomedicines. 2022 Nov 1;10(11):. PMID: 36359302", "BibTeX": "@article{36359302, title={Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS}, author={Martins AF and Neto AC and Rodrigues AR and Oliveira SM and Sousa-Mendes C and Leite-Moreira A and Gouveia AM and Almeida H and Neves D}, journal={Biomedicines}, volume={10}, number={11}}"}}, {"_id": "33375185", "pmid": 33375185, "pmcid": "PMC7822116", "title": "Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?", "journal": "Biomedicines", "authors": ["Salvatore T", "Pafundi PC", "Galiero R", "Rinaldi L", "Caturano A", "Vetrano E", "Aprea C", "Albanese G", "Di Martino A", "Ricozzi C", "Imbriani S", "Sasso FC"], "date": "2020-12-22T00:00:00Z", "doi": "10.3390/biomedicines9010003", "meta_date_publication": "2020 Dec 22", "meta_volume": "9", "meta_issue": "1", "meta_pages": "", "score": 50269.76, "text_hl": "Can @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Exert as an Active Drug on @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@Endothelial Dysfunction@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ Subjects?", "citations": {"NLM": "Salvatore T, Pafundi PC, Galiero R, Rinaldi L, Caturano A, Vetrano E, Aprea C, Albanese G, Di Martino A, Ricozzi C, Imbriani S, Sasso FC. Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? Biomedicines. 2020 Dec 22;9(1):. PMID: 33375185", "BibTeX": "@article{33375185, title={Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?}, author={Salvatore T and Pafundi PC and Galiero R and Rinaldi L and Caturano A and Vetrano E and Aprea C and Albanese G and Di Martino A and Ricozzi C and Imbriani S and Sasso FC}, journal={Biomedicines}, volume={9}, number={1}}"}}, {"_id": "32457625", "pmid": 32457625, "pmcid": "PMC7227439", "title": "Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function", "journal": "Front Pharmacol", "authors": ["Deng M", "Su D", "Xu S", "Little PJ", "Feng X", "Tang L", "Shen A"], "date": "2020-05-08T00:00:00Z", "doi": "10.3389/fphar.2020.00635", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "635", "score": 50269.27, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@Vascular Diseases@@@: A Focused Review on Smooth Muscle Cell Function", "citations": {"NLM": "Deng M, Su D, Xu S, Little PJ, Feng X, Tang L, Shen A. Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function Front Pharmacol. 2020;11():635. PMID: 32457625", "BibTeX": "@article{32457625, title={Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function}, author={Deng M and Su D and Xu S and Little PJ and Feng X and Tang L and Shen A}, journal={Front Pharmacol}, volume={11}, pages={635}}"}}, {"_id": "34646376", "pmid": 34646376, "pmcid": "PMC8490502", "title": "Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function", "journal": "Theranostics", "authors": ["Ding Y", "Zhou Y", "Ling P", "Feng X", "Luo S", "Zheng X", "Little PJ", "Xu S", "Weng J"], "date": "2021-09-09T00:00:00Z", "doi": "10.7150/thno.64706", "meta_date_publication": "2021", "meta_volume": "11", "meta_issue": "19", "meta_pages": "9376-9396", "score": 50265.293, "text_hl": "Therefore, evaluating the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on improving @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@ED@@@ would deepen our knowledge of the therapeutic potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Ding Y, Zhou Y, Ling P, Feng X, Luo S, Zheng X, Little PJ, Xu S, Weng J. Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function Theranostics. 2021;11(19):9376-9396. PMID: 34646376", "BibTeX": "@article{34646376, title={Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function}, author={Ding Y and Zhou Y and Ling P and Feng X and Luo S and Zheng X and Little PJ and Xu S and Weng J}, journal={Theranostics}, volume={11}, number={19}, pages={9376-9396}}"}}, {"_id": "39742025", "pmid": 39742025, "title": "Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats.", "journal": "Cardiovasc Ther", "authors": ["Fouladi M", "Mahmoudabady M", "Gholamnezhad Z", "Shabab S", "Niazmand S", "Salmani H"], "date": "2024-07-09T00:00:00Z", "doi": "10.1155/2024/6025911", "meta_date_publication": "2024", "meta_volume": "2024", "meta_issue": "", "meta_pages": "6025911", "score": 50260.594, "text_hl": "It seems that exercise along with taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can be considered as a therapeutic method by improving @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ and reducing oxidative stress and vascular @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ responses, leading to ameliorating biomarkers function related to @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial damage@@@ in experimental @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ conditions.", "citations": {"NLM": "Fouladi M, Mahmoudabady M, Gholamnezhad Z, Shabab S, Niazmand S, Salmani H. Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats. Cardiovasc Ther. 2024;2024():6025911. PMID: 39742025", "BibTeX": "@article{39742025, title={Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats.}, author={Fouladi M and Mahmoudabady M and Gholamnezhad Z and Shabab S and Niazmand S and Salmani H}, journal={Cardiovasc Ther}, volume={2024}, pages={6025911}}"}}, {"_id": "32825027", "pmid": 32825027, "pmcid": "PMC7503488", "title": "Metformin as a Potential Agent in the Treatment of Multiple Sclerosis", "journal": "Int J Mol Sci", "authors": ["Dziedzic A", "Saluk-Bijak J", "Miller E", "Bijak M"], "date": "2020-08-19T00:00:00Z", "doi": "10.3390/ijms21175957", "meta_date_publication": "2020 Aug 19", "meta_volume": "21", "meta_issue": "17", "meta_pages": "", "score": 50259.09, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and antioxidant features as well as the capacity to restore @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunctions@@@. ", "citations": {"NLM": "Dziedzic A, Saluk-Bijak J, Miller E, Bijak M. Metformin as a Potential Agent in the Treatment of Multiple Sclerosis Int J Mol Sci. 2020 Aug 19;21(17):. PMID: 32825027", "BibTeX": "@article{32825027, title={Metformin as a Potential Agent in the Treatment of Multiple Sclerosis}, author={Dziedzic A and Saluk-Bijak J and Miller E and Bijak M}, journal={Int J Mol Sci}, volume={21}, number={17}}"}}, {"_id": "40409583", "pmid": 40409583, "title": "Suppressing endothelial senescence: A comprehensive analysis of metformin's mechanisms and implications.", "journal": "Life Sci", "authors": ["Shang D", "Zhang X", "Liu H", "Tu Z"], "date": "2025-09-01T00:00:00Z", "doi": "10.1016/j.lfs.2025.123730", "meta_date_publication": "2025 Sep 1", "meta_volume": "376", "meta_issue": "", "meta_pages": "123730", "score": 50256.875, "text_hl": "Preclinical and clinical studies indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-whether administered as monotherapy or in combination regimens-has demonstrated significant potential in the treatment of @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@CVD@@@ by ameliorating @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@. ", "citations": {"NLM": "Shang D, Zhang X, Liu H, Tu Z. Suppressing endothelial senescence: A comprehensive analysis of metformin's mechanisms and implications. Life Sci. 2025 Sep 1;376():123730. PMID: 40409583", "BibTeX": "@article{40409583, title={Suppressing endothelial senescence: A comprehensive analysis of metformin's mechanisms and implications.}, author={Shang D and Zhang X and Liu H and Tu Z}, journal={Life Sci}, volume={376}, pages={123730}}"}}, {"_id": "33162888", "pmid": 33162888, "pmcid": "PMC7581851", "title": "Metformin Ameliorates Gestational Diabetes Mellitus-Induced Endothelial Dysfunction via Downregulation of p65 and Upregulation of Nrf2", "journal": "Front Pharmacol", "authors": ["Sun CC", "Lai YN", "Wang WH", "Xu XM", "Li XQ", "Wang H", "Zheng JY", "Zheng JQ"], "date": "2020-10-09T00:00:00Z", "doi": "10.3389/fphar.2020.575390", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "575390", "score": 50256.508, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Ameliorates Gestational @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes Mellitus@@@-Induced @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@Endothelial Dysfunction@@@ via Downregulation of @GENE_RELA @GENE_5970 @@@p65@@@ and Upregulation of Nrf2", "citations": {"NLM": "Sun CC, Lai YN, Wang WH, Xu XM, Li XQ, Wang H, Zheng JY, Zheng JQ. Metformin Ameliorates Gestational Diabetes Mellitus-Induced Endothelial Dysfunction via Downregulation of p65 and Upregulation of Nrf2 Front Pharmacol. 2020;11():575390. PMID: 33162888", "BibTeX": "@article{33162888, title={Metformin Ameliorates Gestational Diabetes Mellitus-Induced Endothelial Dysfunction via Downregulation of p65 and Upregulation of Nrf2}, author={Sun CC and Lai YN and Wang WH and Xu XM and Li XQ and Wang H and Zheng JY and Zheng JQ}, journal={Front Pharmacol}, volume={11}, pages={575390}}"}}, {"_id": "37759984", "pmid": 37759984, "pmcid": "PMC10525300", "title": "AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation", "journal": "Antioxidants (Basel)", "authors": ["Kang L", "Yi J", "Lau CW", "He L", "Chen Q", "Xu S", "Li J", "Xia Y", "Zhang Y", "Huang Y", "Wang L"], "date": "2023-08-28T00:00:00Z", "doi": "10.3390/antiox12091681", "meta_date_publication": "2023 Aug 28", "meta_volume": "12", "meta_issue": "9", "meta_pages": "", "score": 50255.08, "text_hl": "These results show that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ ameliorates @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ through @GENE_PRKAA1 @GENE_100145903 @@@AMPK@@@-mediated @GENE_YAP1 @GENE_22601 @@@YAP@@@ inhibition.", "citations": {"NLM": "Kang L, Yi J, Lau CW, He L, Chen Q, Xu S, Li J, Xia Y, Zhang Y, Huang Y, Wang L. AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation Antioxidants (Basel). 2023 Aug 28;12(9):. PMID: 37759984", "BibTeX": "@article{37759984, title={AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation}, author={Kang L and Yi J and Lau CW and He L and Chen Q and Xu S and Li J and Xia Y and Zhang Y and Huang Y and Wang L}, journal={Antioxidants (Basel)}, volume={12}, number={9}}"}}]}